Atlas FDA

NEOVENTA'S STAN S31 FETAL HEART MONITOR

FDA premarket approval P020001/S004 · decided 2008-04-11

Approval details

PMA number
P020001
Supplement
S004
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
NEOVENTA'S STAN S31 FETAL HEART MONITOR
Generic name
Analyzer, data, obstetric
Applicant
Neoventa Medical AB
Date received
2007-10-11
Decision date
2008-04-11
Days to decision
183 days
Decision code
APPR
Product code
HEO
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Molndal
Statement
APPROVAL FOR MODIFICATIONS TO THE STAN FETAL HEART RATE CLASSIFICATION AND THE STAN SIMPLIFIED CLINICAL GUIDELINES. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME STAN S31 FETAL HEART MONITOR AND IS INDICATED AS AN ADJUNCT TO FETAL HEART RATE MONITORING TO DETERMINE WHETHER OBSTETRICAL INTERVENTION IS WARRANTED WHEN THERE IS INCREASED RISK OF DEVELOPING METABOLIC ACIDOSIS. THE DEVICE IS INTENDED FOR USE IN PATIENTS WITH: 1) PLANNED VAGINAL DELIVERY; 2) >36 COMPLETED WEEKS GESTATI

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Goldtrace Fetal Spiral Electrode (FSE) (CNS000004) (K243291)Neoventa Medical AB2025-01-17